IRULYA THERAPEUTICS INC

IRLANASDAQ

🏆 #4445 by market capEarnings Nov 10US Equity

$32.96▲ $0.48 (+1.48%)

🌅 Pre-market$32.24▼ 2.17%Regular close · extended-hours price shown

🔔

Track IRLA

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 1.5%

7d▲ 1.2%

14d▼ 1.2%

30d▲ 9.2%

ytd▼ 95.1%

1y▼ 90.1%

🏦Market Cap

$357M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

—

Insufficient data

IRULYA THERAPEUTICS INC

IRLA

Analyst Ratings

Price

$32.96

Total

Raised

Lowered

Avg PT

$70.00

H / L

$72 / $68

Institution	Action	Rating	Date		Upside
Citizens	Upgraded	Market Perform → Market Outperform	2026-09-22	—	—
Cantor Fitzgerald	Reiterated	Overweight	2026-08-18	$70.00	+112.40%
Oppenheimer	Reiterated	Outperform	2026-07-29	—	—
Credit Suisse	Reiterated	Underperform	2022-05-10	—	—
HC Wainwright & Co.	Reiterated	Buy	2022-03-08	—	—
Canaccord Genuity	Downgraded	Buy → Hold	2022-01-27	—	—
JMP Securities	Downgraded	Market Outperform → Perform	2022-01-27	—	—
B of A Securities	Downgraded	Neutral → Underperform	2021-10-26	—	—
Jefferies	Downgraded	Buy → Hold	2021-02-16	—	—
Ladenburg Thalmann	Downgraded	Buy → Neutral	2013-09-16	—	—

Institution

Citizens

Upgraded · Market Perform → Market Outperform · 2026-09-22

—

Cantor Fitzgerald

Reiterated · Overweight · 2026-08-18

$70.00

+112.40%

Oppenheimer

Reiterated · Outperform · 2026-07-29

—

Credit Suisse

Reiterated · Underperform · 2022-05-10

—

HC Wainwright & Co.

Reiterated · Buy · 2022-03-08

—

Canaccord Genuity

Downgraded · Buy → Hold · 2022-01-27

—

JMP Securities

Downgraded · Market Outperform → Perform · 2022-01-27

—

B of A Securities

Downgraded · Neutral → Underperform · 2021-10-26

—

Jefferies

Downgraded · Buy → Hold · 2021-02-16

—

Ladenburg Thalmann

Downgraded · Buy → Neutral · 2013-09-16

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space